LPL Financial’s Evogene EVGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-6,734
Closed -$43.8K 5209
2024
Q2
$43.8K Buy
6,734
+50
+0.7% +$349 ﹤0.01% 4856
2024
Q1
$50.1K Hold
6,684
﹤0.01% 4770
2023
Q4
$56.1K Hold
6,684
﹤0.01% 4636
2023
Q3
$39.2K Buy
6,684
+25
+0.4% +$219 ﹤0.01% 4544
2023
Q2
$71.2K Buy
6,659
+50
+0.8% +$338 ﹤0.01% 4386
2023
Q1
$41.6K Buy
6,609
+200
+3% +$1.49K ﹤0.01% 4332
2022
Q4
$44.9K Sell
6,409
-720
-10% -$5.08K ﹤0.01% 4279
2022
Q3
$59K Sell
7,129
-125
-2% -$1.21K ﹤0.01% 4209
2022
Q2
$56K Sell
7,254
-710
-9% -$6.94K ﹤0.01% 4220
2022
Q1
$104K Sell
7,964
-407
-5% -$5.49K ﹤0.01% 3971
2021
Q4
$137K Buy
8,371
+1,165
+16% +$26.4K ﹤0.01% 4068
2021
Q3
$190K Buy
7,206
+1,257
+21% +$36.7K ﹤0.01% 4003
2021
Q2
$203K Buy
5,949
+1,063
+22% +$41.6K ﹤0.01% 3895
2021
Q1
$246K Buy
4,886
+927
+23% +$57.4K ﹤0.01% 3613
2020
Q4
$186K Buy
+3,959
New +$140K ﹤0.01% 3549

Other funds holding EVGN

LPL Financial's EVGN Position: Q3 2024 in Review

LPL Financial sold out of Evogene (EVGN) in Q3 2024, closing a stake of 6,734 shares — an estimated $43.8K sold.

LPL Financial first reported a position in EVGN in Q4 2020 and held it in 15 quarters. The position peaked at $246K in Q1 2021. 14 funds tracked by Wall St. Rank hold EVGN as of Q3 2024.

  • LPL Financial reported no remaining Evogene position as of Q3 2024 after selling out during the quarter.
  • LPL Financial sold 6,734 Evogene shares in Q3 2024, an estimated $43.8K.
  • LPL Financial first reported a position in Evogene in Q4 2020 and held it in 15 quarters.
  • LPL Financial's Evogene position peaked at $246K in Q1 2021.
  • 14 funds tracked by Wall St. Rank held Evogene as of Q3 2024.

Based on LPL Financial's 13F filing for Q3 2024, filed 8 Nov 2024.